Business Context and Reporting Period
CHAMPIONS ONCOLOGY, INC. (CSBR) filed a Form 8-K on October 16, 2025, reporting the results of its Annual Meeting of Stockholders held on the same date. The Company is incorporated in Delaware and its common stock trades on The Nasdaq Stock Market LLC.
Key Financial Metrics
This filing is a Current Report regarding corporate governance events and does not contain financial statements. Consequently, data regarding revenue, profit, cash flow, margins, debt, and liquidity are not provided in this document.
Material Changes and Voting Results
The filing details the outcomes of three proposals submitted to stockholders:
- Election of Directors: All seven nominees were elected to one-year terms. Voting results ranged from 8,703,235 votes for (David Sidransky, M.D.) to 9,722,734 votes for (Scott R. Tobin). Broker non-votes totaled 931,779 for all director nominees.
- Ratification of Accounting Firm: The appointment of EisnerAmper LLP as the independent registered public accounting firm for the fiscal year ending April 30, 2026, was ratified with 10,659,115 votes for and 729 votes against.
- Executive Compensation: The non-binding advisory resolution regarding the compensation of Named Executive Officers was approved with 9,720,681 votes for and 7,262 votes against.
Guidance, Outlook, and Risks
The filing text does not provide management commentary, financial guidance, outlook, or specific risk factors. The report is limited to the disclosure of voting results as required by Item 5.07.
Investor Verification Checklist
- Verify the full composition of the Board of Directors following the election of the seven nominees.
- Confirm the engagement of EisnerAmper LLP for the fiscal year ending April 30, 2026.
- Review the 2025 Proxy Statement for detailed executive compensation data referenced in the advisory vote.
- Check subsequent filings (e.g., 10-K or 10-Q) for the Company's actual financial performance, as this 8-K contains no financial metrics.